{"name":"Fresenius Kabi Japan","slug":"fresenius-kabi-japan","ticker":"","exchange":"","domain":"","description":"Fresenius Kabi Japan is a subsidiary of Fresenius Kabi, a global healthcare company specializing in infusion therapies and clinical nutrition. The company focuses on developing and providing essential generic and branded pharmaceuticals, as well as medical devices to improve patient care.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQNnZSaWxjLVVfYUFfY2xRcFFFeGR0elVMQ2t2bDJmcUZMRkc3U0llQm9hbXhzNWQ3d0Y4MUhNUVpCbG1abEFseDd4dXVzVEJwTGk0QUxjMWo2M1FRQTZmWGxhZkR4Z2tsTW8zTWVHMFhsTHZqRGtsWVFubFdHdktJZ1dmVTJsWlRyZWxiSGxqMmpHSHFaTHZOazBKdmZ2RW5JeE9PV3dCd2lpTHM?oc=5","date":"2026-04-02","type":"deal","source":"Fierce Pharma","summary":"German CDMO Adragos buys French sterile injectables plant from Sanofi - Fierce Pharma","headline":"German CDMO Adragos buys French sterile injectables plant from Sanofi","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-21","type":"pipeline","source":"Indian Pharma Post","summary":"Fresenius Kabi & TQ Therapeutics join forces to accelerate cell & gene therapy manufacturing - Indian Pharma Post","headline":"Fresenius Kabi & TQ Therapeutics join forces to accelerate cell & gene therapy manufacturing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPWW9JVFdDUTRjdWpCbmNITkdxckpJM0p2NTlXMFNGWThoRkhCVnRFRFY2UUhkaUdocUxCUEthcGVITzZ5VHZhajJDX2d5NHRmOF91T1dKbFI4WjVnUXBJbkU4Q3RQY2ZZa3dNZ2w4THpGXzRVUno4dF94WFY5VlNMUnh2bTZTam1yYmVSeUlFMUZsdDlQZV8tN2hJRk41NXlMNU1KdkVfbUYtOUZVYkNkblhoTXFoT0tMX3BiZWZnUW1KT3c0?oc=5","date":"2025-11-12","type":"pipeline","source":"Fierce Pharma","summary":"Recall roundup: Fresenius, Sun and Teva among drugmakers pulling products in recent weeks - Fierce Pharma","headline":"Recall roundup: Fresenius, Sun and Teva among drugmakers pulling products in recent weeks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZDlDbDRNbXVMTmdkdVNQaW5KbzdPMjN6Q0plVUJnVXVVOXIxd3pQQkd2WjNVcUZBRWMwN3JhSXVuN0ZydzF3Z0ZnMi1JZDVDUk5wTDhseDRxZDNfX1NTY0huQ2loSlQxOVBzT3d5Y0o3WlBOMERBZlN4cjk0Ym9uM1pYNFpmaVpteDNHRXpXUUVNbkNJcmtjSUJyd0RvUzdPTktLN3AxcFJFUQ?oc=5","date":"2025-08-06","type":"deal","source":"Pharmaceutical Technology","summary":"Fresenius Kabi signs global licensing deal for Polpharma’s vedolizumab biosimilar - Pharmaceutical Technology","headline":"Fresenius Kabi signs global licensing deal for Polpharma’s vedolizumab biosimilar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRmJENkZkb0ZZdk8zWHpoSXlJbmlsWkFjemdTRWxFdEo0aklyZlhQMTBwMDF0aG1MS0dQMDE4Y0JHVWNOYk4yeHVfcnJuSUNGcXFjNURHejl5NTJEZXRxRVo5Uzl1Q2Z3N0IzZVlxTU1DTndoLU5jNEtjM0V4d2dhV1RuVjNHVFJtdXg0LV9FODdhTUFvSC1aVWJ0S010TEZqdm5DTFRySjBvcWc?oc=5","date":"2025-07-10","type":"patent","source":"Generics and Biosimilars Initiative","summary":"New denosumab and ustekinumab biosimilar launches in US, Canada and Japan - Generics and Biosimilars Initiative","headline":"New denosumab and ustekinumab biosimilar launches in US, Canada and Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPYlI5cHJDYnRodmREQy1ZSHloSFhiMEIzSU51LUVTS0VDb3ZqUmZHV2xQb21UMkdHYTRDTmpiRnpRbWJzS2x1eklFa05LNE5tYVY5OV9CT3dJa2dUUFRhZFNnaFVMdk00enpka2xwMW44Y19vU1BfSDNWN25Ec1Rmd3hMcVFrOHZhZEJFTVNjeF9TQUhEZGpKdlJ5SWZqbjhST0VPQ2FQT0xzU1ZQaHVfN3JHa2IxMDZhcEpOTFR1WHJ4UThtbUo5aTlYOG8?oc=5","date":"2025-06-17","type":"deal","source":"Center for Biosimilars","summary":"Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan - Center for Biosimilars","headline":"Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNblh6cHNkZGhRb2dGVGM2NDZMVWpBSThqcE8xRFQ0UEpHOHNnaDZ0UXFzLTJaUjU5bEZUTVBOVDVqdXFaSDQteXEweU5XS2djZzNzY09XR2FEUlFkZThtUVdTRVJRVmV1WDhxWVFLejV3VkV5aDdzeHdfWjRLQ1h6YjRJLXVWbUs4NURhTkhwTzVjdDN0M0RvRElaUWxBWEpwc3diYVdjbw?oc=5","date":"2025-05-14","type":"deal","source":"Contract Pharma","summary":"Recipharm, PLG Partner to Accelerate Development Projects - Contract Pharma","headline":"Recipharm, PLG Partner to Accelerate Development Projects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9UMjN2dnBGOHNudGJqU0FCdXItSFBmTS14LWhjVEdBTHVwcV9UbTZoSUtCNWdBaG5QVGJ4LVVMS0tCVHFvZzVSTFY5Z1NTMWhDVzh1QWxYUkk0dl9wdTlqcDJSR01zdW9qNF9pSTJn0gFyQVVfeXFMTXpMTjVzclMzSWRWN1BnRUFMVmVpbTh5aXJvQTlFbDk0ZThoTFdKNWpkVm5IVHhoVnQ1VU9KbExjWXR3MWhENE1VVkRScnJ6NTE0T2hubVJiTFpSMnAyeE1kTXk2RlpBOElqMXhDcU5Ydnhn?oc=5","date":"2024-12-23","type":"deal","source":"koreabiomed.com","summary":"Sam Chun Dang Pharm partners with Fresenius Kabi for Eylea biosimilar commercialization in US, Latin America - koreabiomed.com","headline":"Sam Chun Dang Pharm partners with Fresenius Kabi for Eylea biosimilar commercialization in US, Latin America","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQSXktMnBWQ0d1dWRzVHlZWFJjSUcwVXBQQnpIY0hLRWdTMVRDNWhhQndsWlk2ZkY0cjhHbDNSLTUzbkV0bUp6SjVRVEZCTlJWTlJlamJjOF9xOVZncXNNX3JlTzZRQ3JYWmxocHY5RUlEMkNWM2piRkt3cjJkbXpaS3Etdlp1eXdrZUd0eEFxb0psUzhkRmNpNjR0Ung?oc=5","date":"2024-08-21","type":"pipeline","source":"grandviewresearch.com","summary":"Japan Active Pharmaceutical Ingredients Market Size & Outlook, 2030 - grandviewresearch.com","headline":"Japan Active Pharmaceutical Ingredients Market Size & Outlook, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQVHJiZG5wdXVCZm5GODhRTG1iV0dYT0V6OVVZdzU5clZSamJ0V01hLWt2bVk1Ry1wa1dlQzh1TUdYNU9mV3RDZEl1dkw3OVV4SWN0aHVQeDliWlphWWZfNXM3R1lZdUhGZ3hMMkF5N0RmalV2YXVvTEQ3Z1hocG9MeGwzVndyeEhETEdyRF9hdFhQZw?oc=5","date":"2024-04-04","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Adragos Pharma Expands Drug-Product Capabilities with Key Acquisitions - DCAT Value Chain Insights","headline":"Adragos Pharma Expands Drug-Product Capabilities with Key Acquisitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPbE9TcFluakxBaWNFS3gxaXI4MlRLYUg2WFRJckQ2NXFta3pUT0t6RlR6RVFSOHZOcjktUVlzRlJrX2k5VWkyOENXSW5ZYk4yR1gyMlZwNjljRnc5QXpKQ09FTkttRi1laGhCM21SQTBJamxxbUkwLUViTkZWcm9majhrUDY3NEN2M0hQdzhnZ29aTnh1UjFxX29rU1IwRjhFbGNfOWZVNndyTzVSYkJpdHFldkJ6Q25MSl9HWkVuVVlWSVY3UlVz?oc=5","date":"2023-09-08","type":"deal","source":"Generics and Biosimilars Initiative","summary":"Fresenius Kabi and Formycon reach agreement with J&J, Alvotech and Teva expand partnership - Generics and Biosimilars Initiative","headline":"Fresenius Kabi and Formycon reach agreement with J&J, Alvotech and Teva expand partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPNEpPY0RmZE14djZJSURUXzVPTllxQ1NvRFpBZUdqbzJ2RzM2YUtOZTc4RmpyaTMtcEU0cEEwN2RFeVNtVXNtamxuVl9FbW95QjFGd2w5MW5fWHdyRENHTFZzaExCcG03eFRaeDFmaDB3Rjl5bXBxYUd5dXlYdmp3QmZmenVKaDBjNGVrUWs1LURKaGU0SG92bGI4M0ZSbVFKbGVn?oc=5","date":"2021-09-27","type":"regulatory","source":"The Pharma Letter","summary":"Tavneos approved for ANCA-associated vasculitis in Japan - The Pharma Letter","headline":"Tavneos approved for ANCA-associated vasculitis in Japan","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}